Inhibition of Telomerase Activity by Human Immunodeficiency Virus (HIV) Nucleos(t)ide Reverse Transcriptase Inhibitors: A Potential Factor Contributing to HIV-Associated Accelerated Aging
The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Human immunodeficiency virus (HIV)-infected patients on combination active antiretroviral therapy (cART) are at increased risk of age-related complications. We hypothesized that nucleos(t)ide reverse transcriptase inhibitors (NRTI) may contribute to accelerated aging in HIV-infected individuals on cART via inhibition of telomerase activity. METHODS: Telomerase activity and telomere length (TL) were measured by quantitative polymerase chain reaction in vitro in activated peripheral blood mononuclear cells (PBMCs) cultured with NRTI and ex vivo in PBMCs from uninfected patients exposed to NRTI and from HIV-infected patients on NRTI-containing cART. RESULTS: Lamivudine, abacavir, zidovudine, emtricitabine, and tenofovir significantly inhibited telomerase activity in activated PBMCs in vitro. Tenofovir was the most potent inhibitor of telomerase activity and caused greatest shortening of TL in vitro at the therapeutic concentration of 0.3 μM. PBMCs from HIV-infected patients receiving NRTI-containing cART (n = 39) had significantly lower telomerase activity than HIV-uninfected patients (n = 47; P = .011) and HIV-infected patients receiving non-NRTI-containing cART (n = 11; P < .001). TL was significantly inversely associated with age (P = .009) and the total duration on any NRTI (P = .01). CONCLUSIONS: NRTIs and, specifically tenofovir at therapeutic concentrations, inhibit telomerase activity leading to accelerated shortening of TL in activated PBMCs. The relationship between NRTI, reduced telomerase activity, and accelerated aging requires further investigation in HIV-infected individuals on cART.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Contrastingly, other studies have suggested that the use of NRTIs may potentially activate the tumour suppressor gene p53 in healthy cells, inhibiting telomerase to cause cell death [183,184,185].”
From Current State of Therapeutics for HTLV-1 (2024) · cites this paper as [185]
In the citing paper
“Moreover, NRTIs can also inhibit telomerase and are thought to contribute to accelerated aging phenotypes associated with HIV patients (Hukezalie et al., 2012; Leeansyah et al., 2013).”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Leeansyah et al., 2013
Citations
Cites
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 1×
“Telomerase-containing extracts were prepared from PBMCs, sorted cells, or after in vitro cell culture [24].”
MethodExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Telomere measurement by quantitative PCR
Cawthon, R. M. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.10.e47 · Cited by 3,487
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400 · cited 1×
“TL is maintained via the enzyme telomerase [13], which is a ribonucleoprotein enzyme complex containing a critical”
BackgroundChronic hepatitis B: Update 2009 #
Lok, A. S. F., & McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.23190 · Cited by 2,831
Bryan, T. M., Englezou, A., Dalla-Pozza, L., Dunham, M. A., & Reddel, R. R. (1997) · Nature Medicine · doi:10.1038/nm1197-1271 · Cited by 1,292 · cited 1×
“ening of telomeres has been described in multiple human cell types [40–42] and would be of interest to explore in future studies.”
BackgroundBrenchley, J. M., Karandikar, N. J., Betts, M. R., Ambrozak, D. R., Hill, B. J., Crotty, L. E., Casazza, J. P., Kuruppu, J., Migueles, S. A., Connors, M., et al. (2003) · Blood · doi:10.1182/blood-2002-07-2103 · Cited by 1,073 · cited 1×
“such as chronic immune activation, cytomegalovirus coinfection, cigarette smoking, levels of physical activity, and the use of statins and other ART drugs [7] [43–48].”
BackgroundAlternative lengthening of telomeres: models, mechanisms and implications
Cesare, A. J., & Reddel, R. R. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2763 · Cited by 1,035
Telomeres and telomerase: Their mechanisms of action and the effects of altering their functions
Blackburn, E. H. (2005) · FEBS Letters · doi:10.1016/j.febslet.2004.11.036 · Cited by 838
Cited by
Items 101–153 of 153
HIV-Infected Patients as a Model of Aging
Toljić, B., Milašin, J., Luka, S. R. D., Dragović, G., Jevtović, D., Maslac, A., Ristić‐Djurović, J. L., & Trbovich, A. M. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00532-23 · Cited by 6
Hearps, A. C., Schafer, K. R., High, K. P., & LANDAY, A. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-23246-1_17 · Cited by 6
Self-citationWang, Y., Brummel, S. S., Beilstein-Wedel, E. E., Dagnall, C. L., Hazra, R., Kacanek, D., CHADWICK, E. G., Marsit, C. J., Chanock, S. J., Savage, S. A., et al. (2019) · AIDS · doi:10.1097/qad.0000000000002317 · Cited by 5
Antiretroviral therapy–induced toxicity is associated with increased mRNA expression of telomerase
Li, M., Foli, Y., Amakye, N. Y., Klein, T. M., Selvaraj, S., Lu, L., & Paintsil, E. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.520 · Cited by 5
Incidencia de cáncer en niños chilenos infectados por VIH
Vlllarroel, J., Átvarez, A. M., Chávez, A., Cofré, J., Galaz, M. I., Ledesma, P., Peña, A., Eloísa Vizueta, R., & Wu, E. (2015) · Revista chilena de infectología · doi:10.4067/s0716-10182015000700009 · Cited by 4
Paul, R. H., Garcia-Egan, P. M., Bolzenius, J. D., & Mannarino, J. A. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_185 · Cited by 4
Meireles, J. V. C., & Brito, M. D. V. (2020) · Research Society and Development · doi:10.33448/rsd-v9i9.7436 · Cited by 4
Telomerase: Location, Location, Location?
Beyer, A., & Toro, L. N. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311054 · Cited by 4
Tenofovir for the Prevention of HCC in Patients With Cirrhosis
Arslan, F., & Vahaboğlu, H. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000477 · Cited by 4
HIV-1 Infection, Antiretroviral Therapies, and HIV-Associated Atherosclerosis
Glover, M. C., & Dugas, T. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801078-5.00011-x · Cited by 3
Hu, J., Mao, T., Huang, K., Yang, S., Yu, W., Huang, J., Jin, S., Sun, C., Jiapaer, Z., & Wang, X. (2026) · Cell Cycle · doi:10.1080/15384101.2025.2611968 · Cited by 3
Inhibition of retrotransposition improves health and extends lifespan of SIRT6 knockout micePreprint
Simon, M., Meter, M. V., Ablaeva, J., Ke, Z., González, R. S., Taguchi, T., Cecco, M. D., Leonova, K. I., Kogan, V., Helfand, S. L., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/460808 · Cited by 3
Telomere length dynamics in adults living with HIV: A systematic review
Massamba, M. K. Y., Madurai, L., Archary, D., & Mahomed, S. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13243-4 · Cited by 2
Bukic, E., Dragović, G., Toljić, B., Obradović, B., Jadzic, J. S., Jevtović, D., & Milašin, J. (2024) · Molecular Biology Reports · doi:10.1007/s11033-023-08967-4 · Cited by 2
Zachry, W., Griffith, J. M., Wegzyn, C. M., D'Amico, R. D., Woodward, W. C., & Qian, Q. X. (2013) · Future Virology · doi:10.2217/fvl.13.68 · Cited by 2
A Significance Correlation between Malignant Tumors and Telomerase
AL-Khafaf, M. N., Abubaker, S. R., & Ahmed, A. (2021) · Annals of the Romanian Society for Cell Biology · Cited by 2
Hepatitis C virus: risk factors and disease progression
Grady, B. P. X. (2015) · UvA-DARE (University of Amsterdam) · Cited by 2
Hsu, Y., & Nguyen, M. H. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000507 · Cited by 2
Neurotoxic Consequences of Antiretroviral Therapies
Meeker, R. B., Robertson, K., & Power, C. (2014) · Springer eBooks · doi:10.1007/978-1-4614-9610-6_223-1 · Cited by 2
Fava, V. M., Dallmann-Sauer, M., Orlova, M., Correa-Macedo, W., Olivenstein, R., Costiniuk, C. T., Routy, J., Barreiro, L. B., & Schurr, E. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1805936 · Cited by 1
del Valle, L. G. (2014) · Epidemiology Open Access · doi:10.4172/2161-1165.1000171 · Cited by 1
Envelliment i virus de la immunodeficiència humana
Fajardo, J. A., & Angoiti, J. M. (2015) · Biblioteca Digital de les Illes Balears (Universitat de les Illes Balears) · Cited by 1
Understanding disease through data driven biology
Gross, A. M. (2016) · eScholarship (California Digital Library) · Cited by 1
Neurotoxic Consequences of Antiretroviral Therapies
Meeker, R. B., Robertson, K., & Power, C. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7101-5_223 · Cited by 1
Chen, Y. (2019) · Louisiana State University · doi:10.31390/gradschool_dissertations.4974 · Cited by 1
Beaupère, C. (2014) · theses.fr (ABES) · doi:10.70675/a75378b0z2c4fz47f6z99edz3a60a03b7ee3 · Cited by 1
Zanet, D. L. (2013) · cIRcle (University of British Columbia) · doi:10.14288/1.0165594
HIV-associated COPD : an exploration of risk factors and impacts
Liu, J. C.-Y. (2014) · cIRcle (University of British Columbia) · doi:10.14288/1.0167491
Self-citationInflammation and CMV-associated lymphocyte senescence in chronic HIV infection
Heath, J. (2018) · Memorial University Research Repository (Memorial University)
HIV infection - a new disease of internal medicine
Snopková, S. (2017) · Vnitřní lékařství · doi:10.36290/vnl.2017.103
Ascariz, S., & Carolina, N. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Fernández, I. H. (2019) · idUS (Universidad de Sevilla)
Improved ThwaRTing of Genome Symbionts
Goodier, J. L. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.07.014
Singh, S., Sharma, B., & Siddiqi, N. J. (2019) · Journal of Clinical Research in HIV AIDS and Prevention · doi:10.14302/issn.2324-7339.jcrhap-19-3070
Immunosenescence of CD4+ T cells in male homosexual patients with HIV-1 infectionPreprint
Li, L., Wang, L., Yu, F., Yang, S., Song, S., Tang, Y., Ma, C., & Li, X. (2020) · doi:10.22541/au.158559951.16040888
Gupta, A., & Pulliam, L. (2014) · iDEA - Drexel University Institutional Repository · doi:10.17918/00000830
Prescribing Antiretroviral Therapy
Mathur, P., Bandres, M. V., Ajmal, S., Temesgen, Z., & Koren, D. E. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780197576595.003.0025
Antiretroviral therapy and its cerebral vascular toxicity
Rudd, H., & Toborek, M. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99744-7.00030-4
Novel effects of reverse transcriptase inhibitor supplementation in skeletal muscle of old mice
Osburn, S. C., Smith, M., Wahl, D., & LaRocca, T. J. (2025) · Physiological Genomics · doi:10.1152/physiolgenomics.00115.2024
Huang, T., Li, J., & Wang, S. M. (2022) · Figshare · doi:10.6084/m9.figshare.18482089
Espinosa-Rodríguez, B. A. (2023) · El Repositorio Academico Digital de la UANL (Universidad Autónoma de Nuevo León)
Eficacia y seguridad de la simplificación del tratamiento antirretroviral en la infección VIH
Pasquau Liaño, J. (2019) · Institutional Repository of the University of Granada (University of Granada)
Gianesin, K. (2015) · Padua@research (University of Padova)
Sara, S. (2018) · cIRcle (University of British Columbia)
Gangnonngiw, W., Flegel, T. W., & Kanthong, N. (2026) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2026.105608
Bukic, E., Dragović, G., & Milašin, J. (2025) · Medicinski podmladak · doi:10.5937/mp76-46748
BindingDB Entry 50043794: Telomere maintenance as a target for drug discovery.
BindingDB (2014) · UC San Diego · doi:10.7270/q2t43vkj
Sayed, U., Sultanov, R., Khakimova, L., Dhiaa, A. M., Salih, R. M., Adil, M., & Hussen, S. (2026) · Intelligence-Based Medicine · doi:10.1016/j.ibmed.2026.100522
Metadata
- Authors
- Leeansyah, E., Cameron, P. U., Solomon, A., Tennakoon, S., Velayudham, P., Gouillou, M., Spelman, T., Hearps, A., Fairley, C., Smit, D. V., Pierce, A. B., Armishaw, J., Crowe, S. M., Cooper, D. A., Koelsch, K. K., Liu, J.-P., Chuah, J., & Lewin, S. R.
- Affiliations
- Burnet Institute (AU)
- The Alfred Hospital (AU)
- UNSW Sydney (AU)
- Griffith University (AU)
- Corresponding author
- Leeansyah, Edwin
- ORCID
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-01-09
- Volume
- 207
- Issue
- 7
- Pages
- 1157-1165
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2109413245
- Cited by
- 136
- References
- 50
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 8 · 2023: 4 · 2022: 8 · 2021: 13 · 2020: 13 · 2019: 11 · 2018: 15 · 2017: 10 · 2016: 9 · 2015: 7 · 2014: 17 · 2013: 11
- FWCI
- 10.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Griffith Research Online (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Keywords
- HIV, telomerase inhibition, telomere length, accelerated aging, tenofovir, highly active antiretroviral therapy, peripheral blood mononuclear cells, zidovudine, lamivudine, abacavir, emtricitabine
- MeSH terms
- Emtricitabine, Tenofovir, Abacavir, Adenine, Adult, Aging, Cells, Cultured, Deoxycytidine, Enzyme Activation, Female, HIV, Humans, Leukocytes, Mononuclear, Male, Middle Aged, Regression Analysis, Risk Factors, Time Factors, Zidovudine, Dideoxynucleosides, HIV Infections, Case-Control Studies, Polymerase Chain Reaction, Telomere, Reverse Transcriptase Inhibitors, Telomerase, Lamivudine, Anti-HIV Agents, Antiretroviral Therapy, Highly Active, Young Adult, Telomere Shortening, Organophosphonates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.